William Blair & Company’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $234K | Sell |
8,497
-1,703
| -17% | -$47K | ﹤0.01% | 1358 |
|
2025
Q1 | $289K | Sell |
10,200
-15,740
| -61% | -$446K | ﹤0.01% | 1271 |
|
2024
Q4 | $1.08M | Sell |
25,940
-390
| -1% | -$16.2K | ﹤0.01% | 881 |
|
2024
Q3 | $1.76M | Sell |
26,330
-170
| -0.6% | -$11.4K | 0.01% | 745 |
|
2024
Q2 | $3.15M | Sell |
26,500
-4,815
| -15% | -$572K | 0.01% | 582 |
|
2024
Q1 | $3.34M | Sell |
31,315
-3,601
| -10% | -$384K | 0.01% | 565 |
|
2023
Q4 | $3.47M | Sell |
34,916
-6,369
| -15% | -$633K | 0.01% | 542 |
|
2023
Q3 | $4.26M | Sell |
41,285
-4,657
| -10% | -$481K | 0.02% | 471 |
|
2023
Q2 | $5.58M | Buy |
45,942
+29,043
| +172% | +$3.53M | 0.02% | 418 |
|
2023
Q1 | $2.6M | Buy |
16,899
+1,306
| +8% | +$201K | 0.01% | 596 |
|
2022
Q4 | $2.8M | Buy |
15,593
+822
| +6% | +$148K | 0.01% | 555 |
|
2022
Q3 | $1.75M | Buy |
14,771
+20
| +0.1% | +$2.37K | 0.01% | 646 |
|
2022
Q2 | $2.11M | Sell |
14,751
-860
| -6% | -$123K | 0.01% | 624 |
|
2022
Q1 | $2.69M | Buy |
15,611
+1,724
| +12% | +$297K | 0.01% | 620 |
|
2021
Q4 | $3.53M | Buy |
13,887
+590
| +4% | +$150K | 0.01% | 573 |
|
2021
Q3 | $5.12M | Buy |
13,297
+448
| +3% | +$172K | 0.02% | 452 |
|
2021
Q2 | $3.02M | Sell |
12,849
-5,973
| -32% | -$1.4M | 0.01% | 589 |
|
2021
Q1 | $2.47M | Buy |
18,822
+3,529
| +23% | +$462K | 0.01% | 620 |
|
2020
Q4 | $1.6M | Sell |
15,293
-1,790
| -10% | -$187K | 0.01% | 711 |
|
2020
Q3 | $1.21M | Buy |
17,083
+1,022
| +6% | +$72.3K | 0.01% | 706 |
|
2020
Q2 | $1.03M | Buy |
+16,061
| New | +$1.03M | ﹤0.01% | 713 |
|